DNER and asthma: BET inhibitors or a better understanding of how they inhibit inflammation may have potential for the development of therapeutic strategies for the treatment steroid resistant exacerbations of asthma and other chronic obstructive airways diseases where these mechanisms may operate (e.g. chronic obstructive pulmonary disease).